ALK and inflammatory myofibroblastic tumor: While preoperative diagnosis of IMTs is generally challenging, neoadjuvant ALK inhibitor therapy is specifically considered in cases where IMT has been confirmed through preoperative tissue sampling and where the tumor is deemed initially unresectable [54, 60, 64].